In our clinical framing, medication intelligence is the use of dose-level adherence data, clinical knowledge, validated behavioral methods, and AI to understand how a therapy is actually working in a patient's life, and to respond to what it reveals. AI is what will take this from static reports to continuous reasoning across patient medication-taking behavior.
Across the field, that reasoning still rests on the same foundation: the administrative record of refills and claims. We begin one layer deeper, at the medication-taking behavior itself.
Foundational research and insights from Steve Feldman and Deepak Sirdeshmukh on patient accountability, trust, and medication adherence here.
A patient who applies half a fingertip unit, or takes half a tablet, looks adherent on every refill record. Only a measurement of amount reveals it. That measurement lets the intelligence tell a tolerability problem from a memory problem, and respond to the right one.
Dose-level measurement from the original container, for oral solids and for topicals alike, with no change to how the patient stores or takes the medication. Topicals are a category proxy methods cannot address at all.
Brief survey-based instruments that place each patient on the dimensions predicting response.
Designed to read the behavior, classify the patient, name the parameter in question, and select a clinician-reviewed message matched to the person.
Periodic reporting across all patients and all parameters, with the trajectory of each compliance pattern and the modeled effect of intervention.
We are building MyAide so that every response it produces is shaped by the MyAide™ Constitution, a written framework of operating principles that integrates our research on trust, accountability, and medication adherence with established clinical safety standards.
This matters for one reason: a clinician will be able to ask what shaped any given message, and get an answer. The guidance is grounded, traceable, and open to review. As the platform develops, the constitution is what gets refined, by clinical judgment, in the open, rather than buried in model weights.
Want to see how it works in practice? Talk to us.
MyAide is being built to draw on many sources and inputs, and to deliver to the clinician recommendations for how best to engage and intervene. The intelligence is designed around five layers of observed behavior, each one sharpening the others.
We do not infer medication behavior. We measure it.
Observed dose-level behavior, from oral and topical therapies alike, paired with a patient's behavioral profile and lived experience, is a richer and more trustworthy basis for action than any reconstruction from claims. There is no doubt about the amount, because the amount is measured.
Nothing about the patient's routine changes. There is no app to open as a precondition, no device to wear, no behavior to perform. The signal is gathered from the original container, quietly, which is precisely why it can be trusted: the measurement does not interfere with the behavior it measures.
Better information, gathered without disruption, and interpreted through a model being built on foundational research in trust, accountability, and medication adherence. That is what medication intelligence means at Sensal Health.
Medication intelligence.Without doubt or disruption.